The Notch pathway can function as either an oncogene or a tumor suppressor, depending on the cellular context. Aberrations in Notch signaling have been implicated in various cancers. Dysregulation can occur through mutations, overexpression, or altered ligand availability, contributing to uncontrolled cell growth, inhibition of differentiation, and resistance to apoptosis.
